Ticker Details
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
IPO Date:	October 5, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.66B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.85 | 2.89%
Avg Daily Range (30 D):	$2.78 | 2.67%
Avg Daily Range (90 D):	$2.34 | 2.23%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.53M
Avg Daily Volume (90 D):	.6M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	2,949
Avg Institutional Trade:	$2.78M
Avg Institutional Trade (30 D):	$4.73M
Avg Institutional Trade (90 D):	$5.54M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.01M
Avg Closing Trade (30 D):	$8.61M
Avg Closing Trade (90 D):	$11.03M
Avg Closing Volume:	101.58K

News

Dec 11, 2025 @ 6:17 PM Rhythm Pharma Strikes Chord As Early PWS Trial Res... Source: Vandana Singh

Aug 19, 2025 @ 6:28 PM New Obesity Drugs May See Premium Pricing Undermin... Source: Vandana Singh

May 7, 2025 @ 11:00 AM Rhythm Pharmaceuticals Reports First Quarter 2025 ... Source: Rhythm Pharmaceuticals, Inc.

Apr 7, 2025 @ 11:00 AM Rhythm Pharmaceuticals Announces Pivotal Phase 3 T... Source: N/A

Mar 18, 2025 @ 11:00 AM Rhythm Pharmaceuticals and Raymond A. Wood Foundat... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.82	$-.75	$-.81
Diluted EPS	$-.82	$-.75	$-.81
Revenue	$51.3M	$48.5M	$32.7M
Gross Profit	$45.8M	$42.96M	$29.06M
Net Income / Loss	$-52.9M	$-46.63M	$-49.5M
Operating Income / Loss	$-52.65M	$-45.3M	$-47M
Cost of Revenue	$5.5M	$5.54M	$3.65M
Net Cash Flow	$-83.67M	$29.83M	$16.96M
PE Ratio